Distributor Novo Nordisk has decided to limit low doses of obesity medication Wegovy in the U.S. as demand outpaces supply. Novo Nordisk, a global healthcare and pharmaceutical company based in Denmark, is limiting the supply of Wegovy to conserve supply for …